Jennifer Drew

Jennifer Drew
Jen has worked for GSK for over 10 years and in this time has gained experience working with a range of antibody formats including mAbs, dAbs, dAb fusions and mAb-dAbs. Recently her work has focused on developability, developing screens for solubility of mAbs targeting high concentration formulation and she is currently leading the in vitro translational work within Molecular Design and Engineering group, working to understand the risks of Mabs having translational issues at an early stage in discovery using a variety of screens.


No data was found

Other Speakers